G Citro
Overview
Explore the profile of G Citro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
725
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Martino C, Marcante M, Malorni W, Citro G, Floridi A, Barcellona P, et al.
Am J Primatol
. 2020 Jan;
9(3):173-187.
PMID: 31986790
Sertoli cell cultures were obtained from isolated seminiferous tubules of adult crab-eating macaques (Macaca fascicularis). Cells were identified by their morphological characteristics and their capacity to produce and release in...
2.
Loche S, Salerno M, Garofalo P, Cardinale G, Licenziati M, Citro G, et al.
J Endocrinol Invest
. 2016 Jul;
39(12):1419-1424.
PMID: 27406716
Purpose: Poor adherence to recombinant human growth hormone (r-hGH) therapy is associated with reduced growth velocity in children with growth hormone deficiency (GHD). This twelve-month observational study was to assess...
3.
Vitale M, Masulli M, Cocozza S, Anichini R, Babini A, Boemi M, et al.
Nutr Metab Cardiovasc Dis
. 2016 May;
26(10):879-85.
PMID: 27212622
Background And Aims: Diabetic women have a more adverse plasma lipid profile than men. Sex differences in dietary habits may play a role, but are little investigated. The study evaluates...
4.
Vitale M, Masulli M, Rivellese A, Babini A, Boemi M, Bonora E, et al.
Eur J Nutr
. 2015 Aug;
55(4):1645-51.
PMID: 26303195
Purpose: The optimal macronutrient composition of the diet for the management of type 2 diabetes is debated, particularly with regard to the ideal proportion of fat and carbohydrates. The aim...
5.
Lo Pomo F, Citro G, Zampino A
J Endocrinol Invest
. 2012 Jun;
35(4):450.
PMID: 22652828
No abstract available.
6.
Zupi G, Citro G, Cucco C, Molinari A, Calcabrini A, Marangolo M, et al.
Cytotechnology
. 2012 Feb;
5(Suppl 1):30-1.
PMID: 22358948
No abstract available.
7.
Citro G, Ginobbi P, Szczylik C
Cytotechnology
. 2012 Feb;
11(Suppl 1):S30-4.
PMID: 22358703
The lack of efficient and specific delivery to target cells still limits the potential application of antisense oligodeoxynucleotides as therapeutic agents in cancer disease. We have covalently linked a polylysine...
8.
Mita L, Baldi A, Diano N, Viggiano E, Portaccio M, Nicolucci C, et al.
Environ Toxicol Pharmacol
. 2011 Nov;
33(1):9-15.
PMID: 22047638
Pregnant adult Balb-C mice were exposed daily to two different doses of Bisphenol A (BPA) by subcutaneous injection beginning on gestational day 1 through the seventh day after delivery. The...
9.
Canino C, Mori F, Cambria A, Diamantini A, Germoni S, Alessandrini G, et al.
Oncogene
. 2011 Oct;
31(26):3148-63.
PMID: 22020330
Here we show that pemetrexed-treated mesothelioma cells undergo accelerated senescence. This is characterized by the secretion of proinflammatory and mitogenic cytokines, reminiscent of an SASP (senescence-associated secretory phenotype). Conditioned media...
10.
Lopez M, Carpano S, Dilauro L, Chiatti L, Vici P, Cavaliere F, et al.
Int J Oncol
. 2011 May;
6(2):363-7.
PMID: 21556546
To determine if lonidamine (LND) could reverse anthracycline resistance In patients with advanced, soft-tissue sarcomas, thirty-six patients were treated with epirubicin (EPI) 120 mg/m(2) i.v. every 3 weeks. Progressive patients...